Did You Know?
Join the conversation on regenerative medicine and neural repair by leaving a comment below, or subscribe to our newsletter for weekly updates on biomedical engineering breakthroughs.
Frequently Asked Questions
What is an ischemic stroke?
An ischemic stroke occurs when a blood clot blocks an artery supplying blood to the brain, cutting off oxygen and leading to the death of brain tissue and the formation of a permanent injury cavity.
How does the injectable biomaterial help repair brain tissue?
Developed at Duke University, the microporous annealed particle scaffold (MAPS) is injected into the stroke cavity where it anchors astrocyte-derived extracellular vesicles. This engineered microenvironment recruits beneficial immune cells, such as macrophages and neutrophils, which stimulate blood vessel growth, axonal remodeling, and functional motor recovery.
Are these stroke treatment findings tested in humans?
No. The research is currently preclinical and has only been evaluated in mouse models using rat-derived extracellular vesicles. Further safety testing and larger animal trials are required before clinical testing in humans can begin.
Delivered more than 24 hours after a stroke in mice, an injectable biomaterial developed by biomedical engineers at Duke University harnesses the immune system to promote vascular repair, neural remodeling, and improved motor performance. The treatment transforms the cavity left behind after an ischemic stroke into a supportive environment for tissue regeneration, according to findings published by the research team.
Transforming the Stroke Cavity with Injectable Biomaterials
Every year, millions of people experience ischemic strokes caused by blood clots. Immediate medical interventions, such as clot-dissolving drugs and mechanical thrombectomy, restore blood flow and preserve threatened brain tissue, but they cannot replace tissue already lost to the infarct. Large strokes leave behind a permanent fluid-filled cavity, and recovery relies heavily on rehabilitation to help surviving brain circuits adapt rather than directly repairing the damaged area.
To achieve this, Segura and her laboratory utilized MAPS, or microporous annealed particle scaffolds. These consist of individual hydrogel microparticles forming a porous microstructure that provides a physical framework for cells to inhabit and build upon.
Harnessing Astrocytes and Extracellular Vesicles for Localized Signaling
To recruit helpful immune cells into the scaffold, the Duke researchers turned to astrocytes, which are star-shaped glial cells that support normal brain function and react rapidly to central nervous system injury. Astrocytes communicate with surrounding cells by releasing extracellular vesicles (EVs), nanoscale packages containing proteins, lipids, and genetic material.
Instead of injecting free EVs into the brain, the team anchored them to the surfaces of the hydrogel microparticles using a chemical reaction. This localized the biochemical signals within the scaffold microstructure, ensuring incoming cells encountered the therapeutic cues directly within the lesion site.
"We are not simply placing a material into the brain," Segura stated. "We are engineering a local environment that can coordinate several parts of the repair response."
Screening various signaling combinations revealed that interleukins and signaling proteins—specifically a combination of IL-4 and C1q—excelled at drawing beneficial immune cells into the damaged tissue. These included macrophages and a surprisingly persistent population of neutrophils.
Rethinking the Role of Neutrophils in Brain Repair
Neutrophils are typically viewed as drivers of acute inflammation and secondary tissue damage during the early stages of a stroke. However, the Duke study indicates that when these cells arrive later and encounter the specific microenvironment engineered by the MAP scaffold, they actively contribute to tissue healing.
When the researchers chemically depleted the neutrophil-rich immune population, blood vessel growth and scaffold remodeling dropped markedly. This depletion experiment confirmed that neutrophils serve as essential contributors to the overall repair sequence rather than purely destructive agents.
Our study demonstrates a potential engineering strategy to recruit and retain these cells at the right time."
Vascular Growth, Axonal Remodeling, and Functional Recovery
The targeted immune response coincided with extensive blood vessel formation throughout the treated stroke cavity. Researchers also documented increased axonal fibers—critical structural components of neurons—both within and immediately surrounding the injury site.
Functional outcomes were tracked using a grid-walking test measuring forelimb placement errors in mice. By eight weeks post-treatment, mice receiving the optimized scaffold showed motor performance statistically indistinguishable from healthy control animals, and these improvements remained sustained throughout the duration of the study.
Control experiments revealed that delivering EVs without the structural MAP scaffold failed to produce comparable vascular repair. This proved that the biomaterial acts as more than a passive drug-delivery vehicle; its interconnected porosity and precise spatial localization of EV signals are vital to therapeutic success.
Preclinical Limitations and Next Steps in Biomaterial Research
While the findings demonstrate substantial tissue recovery in animal models, the work remains strictly preclinical. The treatment was administered via direct injection into the injury site in mice, meaning additional safety evaluations and efficacy trials in larger, clinically relevant animal models are required before human translation.
The current study relied on EVs harvested from primary rat astrocytes. To advance toward scalable clinical manufacturing, the Segura laboratory is currently investigating EVs produced by human induced pluripotent stem cell-derived astrocytes. This alternative source offers tighter control over cargo signaling molecules and improved clinical scalability.
That is how we think about the stroke cavity.
Worth a look